B-cell lymphoma articles within Scientific Reports

Featured

• Article
  19 March 2024 | Open Access

  B-cell receptor signaling activity identifies patients with mantle cell lymphoma at higher risk of progression

  • Simona Gambino
  • , Francesca Maria Quaglia
  •  & Maria Teresa Scupoli

• Article
  29 October 2023 | Open Access

  The synergy of the XPO1 inhibitors combined with the BET inhibitor INCB057643 in high-grade B-cell lymphoma via downregulation of MYC expression

  • Manman Deng
  • , Jinshui Tan
  •  & Bing Xu

• Article
  22 August 2023 | Open Access

  Prognostic value of post-treatment serum soluble interleukin-2 receptor in newly diagnosed diffuse large B-cell lymphoma patients who achieved complete metabolic response following R-CHOP therapy

  • Yuko Shirouchi
  • , Noriko Nishimura
  •  & Dai Maruyama

• Article
  12 August 2023 | Open Access

  An artificial intelligence method using FDG PET to predict treatment outcome in diffuse large B cell lymphoma patients

  • Maria C. Ferrández
  • , Sandeep S. V. Golla
  •  & Ronald Boellaard

• Article
  04 November 2022 | Open Access

  T-cell counts in peripheral blood at leukapheresis predict responses to subsequent CAR-T cell therapy

  • Fumiya Wada
  • , Tomoyasu Jo
  •  & Akifumi Takaori-Kondo

• Article
  24 February 2022 | Open Access

  Comprehensive geriatric assessment as a useful tool in predicting adverse events in elderly patients with diffuse large B-cell lymphoma

  • Toshihiro Tanaka
  • , Rika Sakai
  •  & Kazuo Tamura

• Article
  17 February 2022 | Open Access

  Characterization of the canine CD20 as a therapeutic target for comparative passive immunotherapy

  • Joana N. R. Dias
  • , André Almeida
  •  & Frederico Aires-da-Silva

• Article
  17 January 2022 | Open Access

  Mutated RAS-associating proteins and ERK activation in relapse/refractory diffuse large B cell lymphoma

  • Alexandre Benoit
  • , Elisabeth Bou-Petit
  •  & Koren K. Mann

• Article
  10 December 2021 | Open Access

  Electronic case report forms generation from pathology reports by ARGO, automatic record generator for onco-hematology

  • Gian Maria Zaccaria
  • , Vito Colella
  •  & Sabino Ciavarella

• Article
  10 December 2021 | Open Access

  Diagnostic value of baseline ¹⁸FDG PET/CT skeletal textural features in follicular lymphoma

  • Julie Faudemer
  • , Nicolas Aide
  •  & Charline Lasnon

• Article
  24 November 2021 | Open Access

  Incorporation of next-generation sequencing in clinical practice using solid and liquid biopsy for patients with non-Hodgkin’s lymphoma

  • Mariana Bastos-Oreiro
  • , Julia Suárez-González
  •  & Carolina Martínez-Laperche

• Article
  19 February 2021 | Open Access

  Modified conditioning regimen with idarubicin followed by autologous hematopoietic stem cell transplantation for invasive B-cell non-Hodgkin’s lymphoma patients

  • Chen Tian
  • , Yueyang Li
  •  & Yafei Wang

• Article
  05 February 2021 | Open Access

  Efficacy and safety of new anti-CD20 monoclonal antibodies versus rituximab for induction therapy of CD20⁺ B-cell non-Hodgkin lymphomas: a systematic review and meta-analysis

  • Chengxin Luo
  • , Guixian Wu
  •  & Xi Li

• Article
  03 December 2020 | Open Access

  SIRT3, a metabolic target linked to ataxia-telangiectasia mutated (ATM) gene deficiency in diffuse large B-cell lymphoma

  • Kavita Bhalla
  • , Sausan Jaber
  •  & Ronald B. Gartenhaus

• Article
  03 September 2020 | Open Access

  Population-based epidemiological data of follicular lymphoma in Poland: 15 years of observation

  • Anna Szumera-Ciećkiewicz
  • , Urszula Wojciechowska
  •  & Jan Walewski

• Article
  23 July 2020 | Open Access

  IL-21 Stimulates the expression and activation of cell cycle regulators and promotes cell proliferation in EBV-positive diffuse large B cell lymphoma

  • Yuxuan Wang
  • , Chengcheng Wang
  •  & Liang Wu

• Article
  15 July 2020 | Open Access

  Prognostic significance of interim PET/CT response for the treatment of advanced-stage marginal zone lymphoma in the post-rituximab era

  • Ga-Young Song
  • , Sang Eun Yoon
  •  & Deok-Hwan Yang

• Article
  12 May 2020 | Open Access

  Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy

  • Wei Guo
  • , Yuanyuan Song
  •  & Ou Bai

• Article
  09 March 2020 | Open Access

  Dasatinib exacerbates splenomegaly of mice inoculated with Epstein-Barr virus-infected lymphoblastoid cell lines

  • Ryutaro Kotaki
  • , Masaharu Kawashima
  •  & Ai Kotani

• Article
  26 February 2020 | Open Access

  Type 2 diabetes mellitus compromises the survival of diffuse large B-cell lymphoma patients treated with (R)-CHOP – the PLRG report

  • Joanna Drozd-Sokolowska
  • , Jan Maciej Zaucha
  •  & Wojciech Jurczak

• Article
  17 January 2020 | Open Access

  The relationship between consumption of nitrite or nitrate and risk of non-Hodgkin lymphoma

  • Mengxia Yu
  • , Chenying Li
  •  & Jie Jin

• Article
  10 October 2019 | Open Access

  Pro-oncogenic, intra host viral quasispecies in Diffuse large B cell lymphoma patients with occult Hepatitis B Virus infection

  • Mahua Sinha
  • , Keerthana Sundar
  •  & R. S. Jayshree

• Article
  19 September 2019 | Open Access

  Cytarabine-based induction immunochemotherapy in the front-line treatment of older patients with mantle cell lymphoma

  • Sumita Ratnasingam
  • , Joshua Casan
  •  & Stephen Opat

• Article
  06 September 2019 | Open Access

  Classification of aggressive and classic mantle cell lymphomas using synchrotron Fourier Transform Infrared microspectroscopy

  • Magdalena Kolodziej
  • , Dorota Jesionek-Kupnicka
  •  & Izabela Zawlik

• Article
  18 July 2019 | Open Access

  Systematic Review of Somatic Mutations in Splenic Marginal Zone Lymphoma

  • Carolina Jaramillo Oquendo
  • , Helen Parker
  •  & Jonathan C. Strefford

• Article
  08 July 2019 | Open Access

  Differentiation of single lymphoma primary cells and normal B-cells based on their adhesion to mesenchymal stromal cells in optical tweezers

  • Kamila Duś-Szachniewicz
  • , Sławomir Drobczyński
  •  & Grzegorz Rymkiewicz

• Article
  17 June 2019 | Open Access

  Pulmonary MALT Lymphoma has variable features on CT

  • Wen Deng
  • , Ying Wan
  •  & Jian-qun Yu

• Article
  13 June 2019 | Open Access

  The ion channels and transporters gene expression profile indicates a shift in excitability and metabolisms during malignant progression of Follicular Lymphoma

  • Alberto Magi
  • , Marika Masselli
  •  & Annarosa Arcangeli

• Article
  10 May 2019 | Open Access

  Efficacy of the novel CDK7 inhibitor QS1189 in mantle cell lymphoma

  • Yun Jung Choi
  • , Dong Ha Kim
  •  & Jin Kyung Rho

• Article
  29 March 2019 | Open Access

  The clinical features and prognosis of 100 AIDS-related lymphoma cases

  • Dedong Wu
  • , Chen Chen
  •  & Shuang Hu

• Article
  04 February 2019 | Open Access

  Oxo-aglaiastatin-Mediated Inhibition of Translation Initiation

  • Rayelle Itoua Maïga
  • , Regina Cencic
  •  & Jerry Pelletier

• Article
  29 January 2019 | Open Access

  Multi-omics dataset to decipher the complexity of drug resistance in diffuse large B-cell lymphoma

  • Luc-Matthieu Fornecker
  • , Leslie Muller
  •  & Christine Carapito

• Article
  23 January 2019 | Open Access

  Expression of NOTCH3 exon 16 differentiates Diffuse Large B-cell Lymphoma into molecular subtypes and is associated with prognosis

  • Ditte Starberg Jespersen
  • , Anna A. Schönherz
  •  & Karen Dybkær

• Article
  05 October 2018 | Open Access

  A new pharmacokinetic model for ⁹⁰Y-ibritumomab tiuxetan based on 3-dimensional dosimetry

  • F. Morschhauser
  • , B. Dekyndt
  •  & P. Odou

• Article
  04 October 2018 | Open Access

  Mutation of TP53, translocation analysis and immunohistochemical expression of MYC, BCL-2 and BCL-6 in patients with DLBCL treated with R-CHOP

  • Pekka Peroja
  • , Mette Pedersen
  •  & Outi Kuittinen

• Article
  13 August 2018 | Open Access

  Drug-based perturbation screen uncovers synergistic drug combinations in Burkitt lymphoma

  • K. Tomska
  • , R. Kurilov
  •  & T. Zenz

• Article
  12 July 2018 | Open Access

  Angelica gigas Nakai and Decursin Downregulate Myc Expression to Promote Cell Death in B-cell Lymphoma

  • Eungyoung Kim
  • , Jehyun Nam
  •  & Sang-Woo Kim

• Article
  29 May 2018 | Open Access

  Pneumocystis jirovecii pneumonia in HIV-uninfected, rituximab treated non-Hodgkin lymphoma patients

  • Kai-Che Wei
  • , Chenglen Sy
  •  & Ping-Chin Lai

• Article
  19 April 2018 | Open Access

  Prognostic significances of overexpression MYC and/or BCL2 in R-CHOP-treated diffuse large B-cell lymphoma: A Systematic review and meta-analysis

  • Lu Li
  • , Yanyan Li
  •  & Tong Wang

• Article
  26 February 2018 | Open Access

  Somatic Mitochondrial DNA Mutations in Diffuse Large B-Cell Lymphoma

  • Andy G. X. Zeng
  • , Andy C. Y. Leung
  •  & Angela R. Brooks-Wilson

• Article
  20 February 2018 | Open Access

  Shikonin exerts antitumor activity in Burkitt’s lymphoma by inhibiting C-MYC and PI3K/AKT/mTOR pathway and acts synergistically with doxorubicin

  • Fan Ni
  • , Xianbo Huang
  •  & Xiangmin Tong

• Article
  02 February 2018 | Open Access

  Augmentation of CD134 (OX40)-dependent NK anti-tumour activity is dependent on antibody cross-linking

  • Anna H. Turaj
  • , Kerry L. Cox
  •  & Sean H. Lim

• Article
  21 December 2017 | Open Access

  Voruciclib, a clinical stage oral CDK9 inhibitor, represses MCL-1 and sensitizes high-risk Diffuse Large B-cell Lymphoma to BCL2 inhibition

  • Joyoti Dey
  • , Thomas L. Deckwerth
  •  & Richard A. Klinghoffer

• Article
  06 December 2017 | Open Access

  Efficacy and safety of HD-MTX based systemic chemotherapy regimens: retrospective study of induction therapy for primary central nervous system lymphoma in Chinese

  • Xiao Han
  • , Yali Ji
  •  & Daobin Zhou

• Article
  25 October 2017 | Open Access

  High-risk follicular lymphomas harbour more somatic mutations including those in the AID-motif

  • Taku Tsukamoto
  • , Masakazu Nakano
  •  & Junya Kuroda

• Article
  24 October 2017 | Open Access

  Cytoplasmic cyclin D1 controls the migration and invasiveness of mantle lymphoma cells

  • Simon Body
  • , Anna Esteve-Arenys
  •  & Brigitte Sola

• Article
  19 October 2017 | Open Access

  The international staging system improves the IPI risk stratification in patients with diffuse large B-cell lymphoma treated with R-CHOP

  • Xiaolei Wei
  • , Xiaoxiao Hao
  •  & Yongqiang Wei

• Article
  08 September 2017 | Open Access

  Differential gene expression profiling linked to tumor progression of splenic marginal zone lymphoma

  • Tomonori Higuchi
  • , Yumiko Hashida
  •  & Masanori Daibata

• Article
  06 September 2017 | Open Access

  Immunoregulation by IL-7R-targeting antibody-drug conjugates: overcoming steroid-resistance in cancer and autoimmune disease

  • Masahiro Yasunaga
  • , Shino Manabe
  •  & Yasuhiro Matsumura

• Article
  31 August 2017 | Open Access

  Interleukin-6-dependent growth in a newly established plasmablastic lymphoma cell line and its therapeutic targets

  • Sohtaro Mine
  • , Tsunekazu Hishima
  •  & Harutaka Katano